By VC News Daily

BOSTON, MA, Eyebot, developer of cutting edge rapid point-of-sale eye prescription technologies, today announced the closing of a $6 million seed funding round.

The round was led by AlleyCorp and Ubiquity Ventures with participation from Humba Ventures, Ravelin, and Spacecadet. Previous Eyebot investors Baukunst and Village Global doubled down and joined the round. This strategic infusion of capital will bolster Eyebot’s product development trajectory, grow the team, and accelerate its expansion initiatives.

Established in 2021, Eyebot is a deep tech company operating at the forefront of innovation in the vision care industry. Eyebot specializes in the development of self-serve, rapid vision testing technologies that deliver reliable results in a matter of seconds. Our mission is to eliminate the barriers to affordable vision care and eyewear, by transforming a process that traditionally takes weeks or months into a matter of seconds.

(c) by Massinvestor, Inc. For contact info, please check out our about page.

Source: VC News Daily